Be-Sheng Kuo
Corporate Officer/Principal chez AbGenomics International, Inc.
Profil
Be-Sheng Kuo is Senior Director of Preclinical Development for AbGenomics International, Inc. He was a Senior Scientist II at IDEC Pharmaceuticals Corp.
(now known as Biogen IDEC, Inc.) from 1999 to 2003, Parke-Davis Pharmaceutical Research, Inc. (now known as Pfizer, Inc.) from 1993 to 1999, and Marion Merrell Dow, Inc. from 1988 to 1993.
Dr. Kuo received a PhD in Biopharmaceutics from University of Cincinnati.
Postes actifs de Be-Sheng Kuo
| Sociétés | Poste | Début |
|---|---|---|
AbGenomics International, Inc.
 AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA. | Corporate Officer/Principal | - |
Anciens postes connus de Be-Sheng Kuo
| Sociétés | Poste | Fin |
|---|---|---|
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Directeur Technique/Scientifique/R&D | 01/01/2003 |
| Parke-Davis Pharmaceutical Research, Inc. | Directeur Technique/Scientifique/R&D | 01/01/1999 |
| Marion Merrell Dow, Inc. | Directeur Technique/Scientifique/R&D | 01/01/1993 |
Formation de Be-Sheng Kuo
| University of Cincinnati (Ohio) | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
AbGenomics International, Inc.
AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA. | Health Technology |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
| Parke-Davis Pharmaceutical Research, Inc. | |
| Marion Merrell Dow, Inc. | Health Technology |